Novel class of monospecific and bispecific humanized antibodies that target the insulin-like growth factor type I receptor (IGF-1R)

Details for Australian Patent Application No. 2010343304 (hide)

Owner Immunomedics, Inc.

Inventors Chang, Chien-Hsing; Losman, Michele J.; Goldenberg, David M.

Agent Davies Collison Cave

Pub. Number AU-A-2010343304

PCT Pub. Number WO2011/090492

Priority PCT/ US2010/021345 19.01.10 US

Filing date 12 March 2010

Wipo publication date 28 July 2011

International Classifications

C07K 16/30 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61K 51/00 Preparations containing radioactive substances for use in therapy or testing

C07K 16/46 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

Event Publications

5 July 2012 PCT application entered the National Phase

  PCT publication WO2011/090492 Priority application(s): WO2011/090492

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010343305-Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof

2010343293-Method and apparatus for making resistivity measurements in a wellbore